Search Tag: Women's Health
2024 11 Apr
The 2023 draft recommendation by the U.S. Preventive Services Task Force (USPSTF) to start screening mammography at age 40 has sparked controversy, with a Perspective article in the New England Journal of Medicine by Woloshin et al. challenging its merits. A recent article published in the Journal of Breast Imaging seeks to address the concerns...Read more
2024 11 Apr
The 2023 draft recommendation by the U.S. Preventive Services Task Force (USPSTF) to start screening mammography at age 40 has sparked controversy, with a Perspective article in the New England Journal of Medicine by Woloshin et al. challenging its merits. A recent article published in the Journal of Breast Imaging seeks to address the concerns...Read more
2024 11 Apr
The 2023 draft recommendation by the U.S. Preventive Services Task Force (USPSTF) to start screening mammography at age 40 has sparked controversy, with a Perspective article in the New England Journal of Medicine by Woloshin et al. challenging its merits. A recent article published in the Journal of Breast Imaging seeks to address the concerns...Read more
2024 20 Mar
Biotheranostics, Inc., Hologic’s oncology division, is a proud supporter of the Chicago Cancer Initiative (CCI) out of the Robert H. Lurie Comprehensive Cancer Center at Northwestern Memorial Hospital. CCI’s goal is to decrease cancer incidence and mortality in at-risk communities over the next decade. CCI is empowering residents and working...Read more
2024 20 Mar
Biotheranostics, Inc., Hologic’s oncology division, is a proud supporter of the Chicago Cancer Initiative (CCI) out of the Robert H. Lurie Comprehensive Cancer Center at Northwestern Memorial Hospital. CCI’s goal is to decrease cancer incidence and mortality in at-risk communities over the next decade. CCI is empowering residents and working...Read more
2024 21 Feb
Breast cancer remains a significant health concern, standing as the second leading cause of cancer-related deaths among women in the United States. Despite advancements in detection and treatment, the impact of breast cancer continues to be substantial, with projections indicating over 353,500 new cases and approximately 43,700 deaths expected...Read more
2024 21 Feb
Breast cancer remains a significant health concern, standing as the second leading cause of cancer-related deaths among women in the United States. Despite advancements in detection and treatment, the impact of breast cancer continues to be substantial, with projections indicating over 353,500 new cases and approximately 43,700 deaths expected...Read more
2024 21 Feb
Breast cancer remains a significant health concern globally, despite advancements in screening and treatment. Disparities in screening utilization, in stage at diagnosis and in survival rates persist, particularly among vulnerable populations. A recent study published in JAMA Network Open sheds light on the role of social determinants of health...Read more
2024 21 Feb
Breast cancer remains a significant health concern globally, despite advancements in screening and treatment. Disparities in screening utilization, in stage at diagnosis and in survival rates persist, particularly among vulnerable populations. A recent study published in JAMA Network Open sheds light on the role of social determinants of health...Read more
2024 15 Feb
Evidia invests in expanding and developing its radiology and mammography operations and has recruited Helen Häggström for the assignment. Helen has previously, among other things, been head of Sweden for mammography and x-ray at Unilabs and is a nurse at heart. - I am very happy that Helen Häggström accepted the assignment to be...Read more
2024 15 Feb
Evidia invests in expanding and developing its radiology and mammography operations and has recruited Helen Häggström for the assignment. Helen has previously, among other things, been head of Sweden for mammography and x-ray at Unilabs and is a nurse at heart. - I am very happy that Helen Häggström accepted the assignment to be...Read more
2024 13 Feb
Cervical cancer ranks as the fourth most common cancer among women worldwide, with significant morbidity and mortality rates. A key determinant of prognosis and treatment decisions in cervical cancer is the presence of lymph node involvement. The revised staging system by the International Federation of Gynaecology and Obstetrics (FIGO) in 2018...Read more
2024 13 Feb
Cervical cancer ranks as the fourth most common cancer among women worldwide, with significant morbidity and mortality rates. A key determinant of prognosis and treatment decisions in cervical cancer is the presence of lymph node involvement. The revised staging system by the International Federation of Gynaecology and Obstetrics (FIGO) in 2018...Read more
2024 09 Feb
Europe’s Beating Cancer Plan is a political commitment to turn the tide against cancer and another stepping stone towards a strong European Health Union and a more secure, better-prepared and more resilient EU. In 2020, 2.7 million people in the European Union were diagnosed with cancer, and another 1.3 million people lost their lives to it, including...Read more
2024 08 Feb
In a recent study published in JAMA, researchers delved into the trajectory of breast cancer mortality rates in the United States from 1975 to 2019. Their findings shed light on the remarkable decline in mortality rates and the pivotal role played by advancements in breast cancer treatment. Deep diving into forty years of clinical trials...Read more
2024 08 Feb
In a recent study published in JAMA, researchers delved into the trajectory of breast cancer mortality rates in the United States from 1975 to 2019. Their findings shed light on the remarkable decline in mortality rates and the pivotal role played by advancements in breast cancer treatment. Deep diving into forty years of clinical trials...Read more
2024 06 Feb
Cancer poses a significant threat to public health in Europe, with an estimated 2.78 million new cases reported in 2022 across the European Union Member States, Iceland, and Norway. This alarming figure translates to approximately five new cancer diagnoses every minute. Disturbingly, projections indicate that by 2035, cancer will become the leading...Read more
2024 06 Feb
Cancer poses a significant threat to public health in Europe, with an estimated 2.78 million new cases reported in 2022 across the European Union Member States, Iceland, and Norway. This alarming figure translates to approximately five new cancer diagnoses every minute. Disturbingly, projections indicate that by 2035, cancer will become the leading...Read more
2024 06 Feb
A recent report released by the International Agency for Research on Cancer (IARC) ahead of World Cancer Day sheds light on the escalating burden of cancer worldwide. According to fresh projections, the number of new cancer cases in Europe is anticipated to rise by 22.5 percent over the next twenty years. Globally, there is an estimated 55 percent...Read more
2024 06 Feb
A recent report released by the International Agency for Research on Cancer (IARC) ahead of World Cancer Day sheds light on the escalating burden of cancer worldwide. According to fresh projections, the number of new cancer cases in Europe is anticipated to rise by 22.5 percent over the next twenty years. Globally, there is an estimated 55 percent...Read more
2024 25 Jan
Cervical cancer was once a leading cause of cancer death for women in the United States. Today, screening and prevention have greatly reduced the impact of this form of cancer. Still, approximately 13,960 women in the United States are projected to receive a diagnosis of cervical cancer in 2023 and approximately 4,310 will die from the disease, ...Read more
2023 11 Dec
Hologic was recognized with three IMV ServiceTrak™ Imaging Awards at this year’s RSNA in Chicago, continuing a longstanding track record of excellence in mammography service. The company received awards for Best Service, Best Customer Satisfaction and Best System Performance. This is the 11th consecutive year Hologic has ranked first in the...Read more
2023 07 Nov
Researchers from Karolinska Institute reported that women who receive a false positive mammography are more likely to develop breast cancer over the following 20 years. The team used data from the Stockholm Mammography Screening programme, linked to Swedish nationwide registers, to explore the long-term outcomes following a false-positive...Read more
2023 30 Oct
With the European Council’s revision of breast screening recommendations last year, radiology departments are facing a new era for mammography. With the addition of digital breast tomosynthesis (DBT), also known as 3D mammography, to the radiology toolkit, this opens the way to new advancements in patient health. One of these advancements, contrasted-enhanced...Read more
2023 19 Oct
According to recent survey data from Ohio State University, fewer than half of adults are aware of some of the most common symptoms linked to breast cancer. Data collection was conducted in September and included a sample of 1,004 women. The survey was conducted via web and telephone. The findings revealed that the majority of...Read more
2023 10 Oct
Partnership to Include Integration of Hologic Products, Specifically Designed for Gynecologic Care, into Hands-On Skills Education for OB-GYN Residents Hologic, Inc., a global leader in women’s health announced an innovative new partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical. Hologic becomes...Read more
2023 12 Sep
Oviva Therapeutics, a premier biotech company dedicated to addressing the vast unmet need in women’s health by developing first-in-class therapeutics to preserve ovarian function and consequently extend female healthspan, announced the appointment of Rachel Rimsky Rubin as its new Chief Operating Officer (COO), effective as of September 5, 2023....Read more
2023 11 Sep
A study presented at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer revealed that key reproductive factors such as early menopause, shortened reproductive span, and early age at first birth are associated with elevated risks of lung cancer in women. Researchers from Xiangya Hospital, Changsha,...Read more
2023 30 Aug
A clinical trial is underway to enroll women with breast cancer, with the goal of investigating the effectiveness of behavioural and psychological interventions in mitigating heart damage resulting from anti-cancer treatments. This pioneering initiative, known as the CARDIOCARE project, is being conducted by a consortium of European partners including...Read more